HC Wainwright & Co. Maintains Buy on Lifeward, Raises Price Target to $10
3/19/2026
Impact: 80
Healthcare
HC Wainwright & Co. analyst Swayampakula Ramakanth has maintained a Buy rating on Lifeward (NASDAQ: LFWD) and increased the price target from $4.5 to $10. This adjustment reflects a positive outlook on the company's performance.
AI summary, not financial advice
Share: